Literature DB >> 25105511

What is the risk of infecting a cerebrospinal fluid-diverting shunt with percutaneous tapping?

Lindsey Spiegelman1, Richa Asija, Stephanie L Da Silva, Mark D Krieger, J Gordon McComb.   

Abstract

OBJECT: Most CSF-diverting shunt systems have an access port that can be percutaneously tapped. Tapping the shunt can yield valuable information as to its function and whether an infection is present. The fear of causing a shunt infection by tapping may limit the physician's willingness to do so. The authors of this study investigate the risk of infecting a shunt secondary to percutaneous tapping.
METHODS: Following institutional review board approval, CSF specimens obtained from tapping an indwelling CSF-diverting shunt during the 2011 and 2012 calendar years were identified and matched with clinical information. A culture-positive CSF sample was defined as an infection. If results were equivocal, such as a broth-only-positive culture, a repeat CSF specimen was examined. The CSF was obtained by tapping the shunt access port with a 25-gauge butterfly needle after prepping the unshaven skin with chlorhexidine.
RESULTS: During the study period, 266 children underwent 542 shunt taps. With 541 taps, no clinical evidence of a subsequent shunt infection was found. One child's CSF went from sterile to infected 11 days later; however, this patient had redness along the shunt tract at the time of the initial sterile tap.
CONCLUSIONS: The risk of infection from tapping a shunt is remote if the procedure is done correctly.

Entities:  

Keywords:  cerebrospinal fluid–diverting shunt; hydrocephalus; shunt infection; shunt tapping; ventriculoperitoneal shunt

Mesh:

Year:  2014        PMID: 25105511     DOI: 10.3171/2014.7.PEDS13612

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  3 in total

1.  Quantitative contrast-enhanced ultrasound measurement of cerebrospinal fluid flow for the diagnosis of ventricular shunt malfunction.

Authors:  Robin Hartman; Salavat Aglyamov; Douglas J Fox; Stanislav Emelianov
Journal:  J Neurosurg       Date:  2015-06-19       Impact factor: 5.115

2.  Shunt infusion studies: impact on patient outcome, including health economics.

Authors:  Afroditi-Despina Lalou; Marek Czosnyka; Matthew R Garnett; Eva Nabbanja; Gianpaolo Petrella; Peter J Hutchinson; John D Pickard; Zofia Czosnyka
Journal:  Acta Neurochir (Wien)       Date:  2020-02-20       Impact factor: 2.216

Review 3.  Comparison of the use of ventricular access devices and ventriculosubgaleal shunts in posthaemorrhagic hydrocephalus: systematic review and meta-analysis.

Authors:  Daniel M Fountain; Aswin Chari; Dominic Allen; Greg James
Journal:  Childs Nerv Syst       Date:  2015-11-11       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.